Stefan Pöhlmann - Concepedia

Author

Stefan Pöhlmann

Also Known As

Kollmus, Heike, Markus Hoffmann, Pöhlmann, Stefan, S Pohlmann, S Pöhlmann, S. Pohlmann, S. Pöhlmann, Stefan H. Pöhlmann, Stefan Phlmann, Stefan Pohlmann

406

Publications

52.1K

Citations

H-Index

Concepts

All Affiliations

German Primate Center University of Göttingen Medizinische Hochschule Hannover Friedrich-Alexander-Universität Erlangen-Nürnberg University of Pennsylvania

About

Stefan Pöhlmann is an author at German Primate Center specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	100	39.2K
2	Natural Sciences	7	7	869
3	Engineering	3	3	118
4	Public Health	2	2	855
5	Health Sciences	1	1	44

Stefan Pöhlmann

201

Publications

48.2K

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder, Cell MedicineViral PathogenesisImmunologyIs BlockedVirology	2020	21.1K
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells Markus Hoffmann, Hannah Kleine‐Weber, Stefan Pöhlmann Molecular Cell Virus StructureMultibasic Cleavage SiteViral EvolutionSpike ProteinRespiratory Diseases	2020	2.1K
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response Ilona Glowacka, Stephanie Bertram, Marcel A. Müller, Journal of Virology Membrane FusionProtease InhibitorsHumoral Immune ResponseBiochemistryReduces Viral Control	2011	1.2K
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies Markus Hoffmann, Prerna Arora, Rüdiger Groß, Cell ImmunologyVirologyViral Structural ProteinMedicineSars-cov-2 Variants B.1.351	2021	1K
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic Markus Hoffmann, Nadine Krüger, Sebastian Schulz, Cell Covid-19 PandemicImmunologyAntibody-mediated NeutralizationAntiviral TherapyAntiviral Response	2021	945
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Adeline Heurich, Heike Hofmann-Winkler, Stefanie Gierer, Journal of Virology	2013	922
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry Heike Hofmann, Krzysztof Pyrć, Lia van der Hoek, Proceedings of the National Academy of Sciences Human Coronavirus Nl63Molecular VirologyTarget CellsSevere DiseaseViral Pathogenesis	2005	877
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells Markus Hoffmann, Hannah Kleine‐Weber, Nadine Krüger, Viral PathogenesisImmunologyNcov-2019 SpikeCovid-19 EpidemiologyViral Structural Protein	2020	756
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Cell VaccinationVirus StructureMolecular VirologyPotent NeutralizationMedicine	2020	650
Protease inhibitors targeting coronavirus and filovirus entry Yanchen Zhou, P. Vedantham, Kai Lü, Antiviral Research Protease InhibitorsAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral Drug	2015	616

Page 1